News
-
-
-
-
PRESS RELEASE
EQS-Adhoc: LR HEALTH & BEAUTY SE RECEIVES SUPPORTING VOTING INTENTIONS BY 69.57% OF THE ADJUSTED NOMINAL AMOUNT FOR TEMPORARY WAIVERS UNDER THE 2024/2028 BONDS
LR Health & Beauty SE has received support from bondholders representing 69.57% of adjusted nominal amount for temporary waivers under the 2024/2028 bonds -
-
-
-
PRESS RELEASE
LR Health & Beauty SE reports on business development in the third quarter of 2025
LR Health & Beauty SE reports on business development in Q3 2025, with sales of EUR 66.0 million and EBITDA of EUR 2.9 million. Focus on fragrance segment, capital structure, and earnings guidance revision -
-
PRESS RELEASE
EQS-Adhoc: LR Health & Beauty SE: BREACH OF LEVERAGE COVENANT / NO INTEREST PAYMENT / STANDSTILL NEGOTIATIONS WITH AN AD HOC GROUP OF BONDHOLDERS / APPOINTMENT OF A REPUTABLE FIRM TO SUPPORT ...
LR Health & Beauty SE announces breach of leverage covenant, no interest payment, and standstill negotiations with bondholders. Firm appointed to support financial restructuring
